Mohammed Khaleequr Rahman

Mohammed Khaleequr Rahman

Director Director DIN 07015837
DIN 07015837 First appointment Jan 1994 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 1994
Shareholding value •••• Premium profile

About Mohammed Khaleequr Rahman

Data last updated:

Mohammed Khaleequr Rahman was a Director at Deccan Remedies Ltd (1994–2025) and Director at Gennex Laboratories Limited (2024–2025). The companies operate in Pharma.

DIN 07015837
Primary Designation Director
Industry Pharma
First Appointment 31 Jan 1994

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Deccan Remedies Ltd U72200TG1994PLC016962
Director31 Jan 19941994₹44.53 Cr (FY 2025)Active
Gennex Laboratories Limited L24230TG1990PLC011168
Director06 Sep 20241990₹91.62 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Deccan Remedies Ltd
Gennex Laboratories Limited
Premium access

Shareholding and investment profile for Mohammed Khaleequr Rahman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Khaleequr Rahman

Mohammed Khaleequr Rahman was first appointed on 31 Jan 1994 as Director at Deccan Remedies Ltd. The most recent appointment on record is 06 Sep 2024 at Gennex Laboratories Limited.

Mohammed Khaleequr Rahman held 2 earlier board appointments: Deccan Remedies Ltd (Director, 31 Jan 1994 to 09 Oct 2025); Gennex Laboratories Limited (Director, 06 Sep 2024 to 14 Feb 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available